SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?


To: JessiDani who wrote (1028)12/29/1997 11:55:00 PM
From: docsox  Respond to of 7054
 
Bingo!!

You are absolutely correct about the value to the customer of the TAD. Since proverbs are being bantied about, "A bird in the hand is worth two in the bush" comes to mind. Accounts receivable have no immediate value to the holder. They represent " a bird in the bush".Offering 82% of the value immediately provides lifeblood to the small company (or even the large one). A previous post expressed concern that ACRT "charges 18% interest". That is not the case. ACRT gets the bird out of the bush and into your hand for only 18%. There is no way that can be compared to borrowing the value of the accounts receivable at a "more favorable" interest rate, then having the monthly P&I be a drain on your cash flow.

There seems to be a lack of understanding of how this all flows, and why it has value. More proverbs: "Beauty is in the eye of the beholder." Likewise, the value of the TAD is in the eye of the beholder. Mr. Pink is not a part of that equation.

David



To: JessiDani who wrote (1028)12/30/1997 10:19:00 AM
From: Mr. Pink  Read Replies (1) | Respond to of 7054
 
Yes, but how much value in addition to the TADs is the "process" worth. Mr. pink doubts that the process can not be duplicated at a cost of roughly 1X book. This is not proprietary.

mr. pink